subject: Aarkstore Enterprise---thermogenesis Corp. (kool) - Financial And Strategic Analysis Review [print this page] ThermoGenesis CorpThermoGenesis Corp. is a medical equipment company. It designs, manufactures and markets automated and semi-automated devices and single-use processing disposables. The Company currently operates in three areas in stem cell therapeutics markets: storage products, cell processing products and wound care products. The companys products enable hospitals and blood banks to manufacture therapeutic dose of stem cells and wound healing proteins from the patients own blood in less than one hour. The companys principal product line includes BioArchive, AXP/MXP, ThermoLine and CryoSeal. Vantus Veterinary Stem Cell Laboratories (Vantus) is a wholly owned subsidiary of the company.
ThermoGenesis Corp. Key Recent Developments
May 06, 2010 ThermoGenesis Reports Net Revenues Of $4.7 Million In Q1 2010
May 06, 2010 ThermoGenesis Appoints David W. Carter As Board Member
Mar 16, 2010 ThermoGenesis Signs Agreement With Fenwal
Feb 04, 2010 ThermoGenesis Reports Net Revenues Of $5.9 Million In Q2 Fiscal 2010
Feb 04, 2010 ThermoGenesis Renews Distribution Agreement With GE Healthcare For Its AXP Product Line
This comprehensive SWOT profile of ThermoGenesis Corp. provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including,
- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
